Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.2200
-0.0400
(-3.17%)
At close: April 4 at 4:00:02 PM EDT
1.2400
+0.02
+(1.64%)
After hours: April 4 at 7:35:33 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 1 | 1 | 1 |
Avg. Estimate | -0.1 | -0.09 | -0.38 | -0.41 |
Low Estimate | -0.1 | -0.09 | -0.38 | -0.41 |
High Estimate | -0.1 | -0.09 | -0.38 | -0.41 |
Year Ago EPS | -0.1 | -0.09 | -0.36 | -0.38 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 11 | 8 |
Avg. Estimate | 1.48M | 1.77M | 5.89M | 2.38M |
Low Estimate | -- | -- | -- | -- |
High Estimate | 3.8M | 5.6M | 15M | 8M |
Year Ago Sales | 3.41M | 1.11M | 8.33M | 5.89M |
Sales Growth (year/est) | -56.55% | 58.94% | -29.32% | -59.68% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.09 | -0.1 | -0.09 | -0.08 |
EPS Actual | -0.1 | -0.09 | -0.07 | -0.07 |
Difference | -0 | 0.01 | 0.02 | 0.01 |
Surprise % | -3.20% | 14.80% | 20.89% | 15.39% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.1 | -0.09 | -0.38 | -0.41 |
7 Days Ago | -0.1 | 0 | -0.26 | 0 |
30 Days Ago | -0.1 | 0 | -0.26 | 0 |
60 Days Ago | -0.1 | 0 | -0.26 | 0 |
90 Days Ago | -0.1 | 0 | -0.26 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | -- | 1 |
Up Last 30 Days | 1 | 1 | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
TSHA | -2.00% | -5.63% | -6.77% | -7.89% |
S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
Reiterates | Needham: Buy to Buy | 2/27/2025 |
Maintains | Chardan Capital: Buy to Buy | 2/26/2025 |
Reiterates | Needham: Buy to Buy | 1/6/2025 |
Maintains | Canaccord Genuity: Buy to Buy | 11/15/2024 |
Maintains | Chardan Capital: Buy to Buy | 11/14/2024 |
Reiterates | Needham: Buy to Buy | 11/14/2024 |
Related Tickers
NGNE Neurogene Inc.
8.79
-9.10%
SLDB Solid Biosciences Inc.
3.1150
-8.52%
QURE uniQure N.V.
8.96
-8.10%
EWTX Edgewise Therapeutics, Inc.
11.51
-15.24%
ALXO ALX Oncology Holdings Inc.
0.5159
-3.23%
TNYA Tenaya Therapeutics, Inc.
0.4988
-4.08%
RGNX REGENXBIO Inc.
6.29
-5.70%
RCKT Rocket Pharmaceuticals, Inc.
5.12
-7.91%
FDMT 4D Molecular Therapeutics, Inc.
2.7700
-3.99%
VRCA Verrica Pharmaceuticals Inc.
0.5301
+26.21%